Tricyclic inhibitors of the GPII.sub.b III.sub.a receptor

Details Tricyclic inhibitors of the GPII.sub.b III.sub.a receptor Tricyclic inhibitors of the GPII.sub.b III.sub.a receptor

1993-07-29

1996-02-20

Bond, Robert T.

Organic compounds -- part of the class 532-570 series

Organic compounds

Unsubstituted hydrocarbyl chain between the ring and the -c-...

C07D48704, A61K 3155

Patent

active

054930200

ABSTRACT:
A trycylic benzodiazepine derivative which acts as a nonpeptidyl platelet aggregation inhibitor is provided. This inhibitor potently inhibits fibrinogen binding to the GPII.sub.b III.sub.a receptor and is provided in therapeutic compositions for the treatment of diseases for which blocking platelet aggregation is indicated. These nonpeptidyl inhibitors are provided in combination with thrombolytics and anticoagulants.

REFERENCES:
patent: 5250679 (1993-10-01), Blackburn et al.
Hawiger, J., Atherosclerosis Review 21:165-186 (1990).
Hynes, R. O., Cell 48: 549 (1987).
Kieffer et al., Ann. Rev. Cell. Biol. 6: 329-357 (1990).
Roth, J. R., Immunology Today 13(2): 100-105 (1992).
Ruoslahti, J. Clin. Invest. 87: 1-5 (1991).

Affiliated with

Also associated with

Rating

Tricyclic inhibitors of the GPII.sub.b III.sub.a receptor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tricyclic inhibitors of the GPII.sub.b III.sub.a receptor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tricyclic inhibitors of the GPII.sub.b III.sub.a receptor will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1357009